Revenio Group Oyj (LON:0KFH)

Market Cap	541.74M
Revenue (ttm)	85.86M
Net Income (ttm)	15.30M
Shares Out	n/a
EPS (ttm)	0.57
PE Ratio	35.42
Forward PE	n/a
Dividend	0.35 (1.45%)
Ex-Dividend Date	Apr 11, 2025

Volume	221
Average Volume	5,717
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	17.59 - 41.32
Beta	1.38
RSI	31.25
Earnings Date	Apr 29, 2025

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in the United States, Finland, and internationally. The company offers intraocular pressure measuring devices, retinal imaging equipment, perimeters, as well as software solutions under the iCare brand. Its product portfolio includes iCare IC100, IC200, ST500, TONOVET Pro, and TONOVET Plus tonometers; iCare HOME2, a home intraocular pressure monitor; and iCare Sensors, an accessories for iCare...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2001
• Employees: 241
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KFH

Financial Performance

In 2024, Revenio Group Oyj's revenue was 103.82 million, an increase of 7.27% compared to the previous year's 96.79 million. Earnings were 18.50 million, a decrease of -3.20%.

Financial numbers in EUR